Medannex
Edinburgh
About Medannex
Medannex's goal is to create a first-in-class antibody therapy to improve the lives of people impacted by cancers and autoimmune diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $13.9M
- Funding stage: Early Stage Venture
- Last round: Grant (Jul 2024)
- Website: medannex.org
- Phone: +44(0)1313574251
Industries & Categories
Biotechnology, Clinical Trials
Social Profiles
Canonical: https://fsome.com/organization/medannex-71444 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.